Today is Wednesday, June 24, 2026.

The Early Bird Index today is 88.64.

New to this newsletter? Sign up here

^{PRESENTED BY STRATIFIND}

Cancer remains one of the largest and most important healthcare markets in the world, yet selecting the right treatment for the right patient remains one of oncology’s greatest challenges. Physicians routinely choose among chemotherapy, immunotherapy, targeted therapies, radiation, and combination approaches, often with limited information about which treatment is most likely to benefit a particular patient.

Stratifind is developing RainDanceEQ™, a precision oncology platform designed to help physicians make more informed treatment decisions through a more comprehensive understanding of each patient’s cancer. By integrating multiple layers of tumor information and advanced analytics into a single actionable report, the company aims to provide insights that go beyond traditional testing approaches.

Founded by healthcare investment banker Igor Sokolovsky and physician-scientist Dr. Partha Ray, Stratifind is pursuing an opportunity at the intersection of molecular diagnostics, precision medicine, and oncology decision support. Successful oncology diagnostics companies have created substantial value for patients, providers, and investors alike, and Stratifind seeks to establish a differentiated position within this growing sector.

The company is currently conducting a financing round through Netcapital and welcomes conversations with investors, family offices, healthcare professionals, and strategic partners interested in the future of cancer diagnostics and precision oncology.

Despite posting good financial earnings results on Tuesday, FedEx $FDX ( ▼ 3.51% ) fell 6.46% in after-hours trading due to trade policy challenges.

Financials: FedEx reported earnings of $6.31 per share in the past quarter, and revenue of $25 billion. Both were better than expected.

Details: Capital spending fell during the quarter. The Federal Express segment benefited from higher package yields and increased export package volume.

Powering the Story: But several issues stood out. The margin fell during the quarter. And the Federal Express segment faced what the company calls “the financial impacts of global trade policy changes.” This was basically a fancy way of saying the trade war was a problem.

Early Bird’s Nest Egg Gains: Recent global trade policy changes have hurt FedEx mainly by reducing China-U.S. shipping demand, ending the de minimis exemption for low-value parcels, and raising customs/compliance costs.

Final Thoughts: Consider this a setback for FedEx. The stock was up 34.40% in 2026.

Notable Earnings Today: Micron Technology (Nasdaq: MU), Paychex (Nasdaq: PAYX), Trip.com Group (Nasdaq: TCOM), H.B. Fuller (NYSE: FUL), Worthington Steel (NYSE: WS), MillerKnoll (Nasdaq: MLKN), Jefferies (NYSE: JEF), Daktronics (Nasdaq: DAKT), LiveOne (Nasdaq: LVO), Methode Electronics (NYSE: MEI), MoneyHero (Nasdaq: MNY), NovaGold Resources (NYSE American: NG), PodcastOne (Nasdaq: PODC).

Notable IPOs Today: N/A.

Notable Equity Crowdfunding Campaigns Ending Today: p!ng (Wefunder).

Notable Economic Events Today: Current Account (8:30 a.m. ET), Building Permits (8:30 a.m. ET), New Home Sales (10:00 a.m. ET), Crude Oil Inventories (10:30 a.m. ET), Fed Bank Stress Test Results (4:00 p.m. ET).

Nike $NKE ( ▼ 1.88% ) ticked up 0.98% in after-hours trading on Tuesday after announcing that David M. Denton will join as chief financial officer, replacing Matthew Friend.

Details: Denton was most recently CFO at Pfizer $PFE ( ▼ 1.44% ). The pharmaceutical company will now turn to an interim CFO while starting a search for a permanent replacement.

Background: Nike’s stock is down over 70% in the past 5 years as the company deals with mixed earnings and declining sales.

Final Thoughts: Nike will report its next earnings results on June 30.

KB Home $KBH ( ▲ 0.4% ) jumped 3.52% in after-hours trading on Tuesday, even though the homebuilding company posted mixed financial results.

Financials: KB Home reported earnings of 43 cents per share in the past quarter, which were lower than expected. Revenue was $1.11 billion, which was better than expected.

Final Thoughts: It’s a recovery for KB Home. The stock was down 7.60% this year.

Tech Retreat: US Chip Stocks Plunge as AI Selloff Ripples Across From Asia (Bloomberg)

Second Thoughts: AI stock slump raises the question if investors are just taking profits or getting very nervous (Associated Press)

Going Industrial: Alphabet’s stock is set to join the Dow, pivoting index’s industrial roots toward tech (MarketWatch)

Reduction: Vitalik Buterin says Ethereum Foundation will cut budget 40% in major reset (CoinDesk)

A Request: CryptoQuant says Strategy should pause bitcoin purchases and rebuild cash reserves (The Block)

Forward to a friend and tell them to sign up here.

Pick winning stocks: Upgrade to Early Bird Prime.

Become a smarter investor: Get Early Bird Exclusives

Want more investing tips? Listen to the podcast.

Show Your Support: Buy Me a Coffee.

Questions or comments? Hit reply to reach out.

_{The contents of Early Bird are intended for informational and entertainment purposes only. They do not constitute trade or investment recommendations, and they are not financial or legal advice. Readers are encouraged to consult licensed professionals for personalized guidance regarding their financial or legal situations.}